Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Major Burger

Surgery Cape Girardeau, MO Doctor of Osteopathy

NPI 1760757959 CMS profile 3225894

60 Doctors Park, Cape Girardeau, MO 63703

Open in the dashboard

General payments

$7,744

86 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Major Burger of Cape Girardeau, MO is reported in the CMS Open Payments database as having received $7,744 across 86 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19 1
2024 General $597 11
2023 General $145 8
2022 General $409 11
2021 General $322 13
2020 General $16 1
2019 General $6,237 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Major Burger
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Major Burger were reported at $19. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Major Burger Surgery median Middle half National median
2019 $6,237 $253 $82–$1,521 $163
2020 $16 $131 $40–$706 $114
2021 $322 $168 $50–$904 $132
2022 $409 $224 $76–$1,218 $149
2023 $145 $253 $82–$1,255 $160
2024 $597 $279 $90–$1,381 $164
2025 $19 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $6,312 45 payments
  2. Ethicon US, LLC $529 11 payments
  3. Allergan Inc. $193 7 payments
  4. Boston Scientific Corporation $174 4 payments
  5. W. L. Gore & Associates, Inc. $119 5 payments
  6. Smith+Nephew, Inc. $91 5 payments
  7. Innovation Technologies Inc $88 1 payment
  8. PolyNovo North America LLC $77 1 payment
  9. Kub Technologies Inc. $48 1 payment
  10. Molli Surgical (us) Inc $42 1 payment
  11. Other $71 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $4,000 1 payment
  2. Food and Beverage $2,302 71 payments
  3. Travel and Lodging $1,442 14 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $6,312 45 payments
  2. Echelon Flex $240 3 payments
  3. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $205 8 payments
  4. SpyGlass Discover $161 3 payments
  5. Irrisept $88 1 payment
  6. NOVOSORB BTM $77 1 payment
  7. GORE ENFORM Preperitoneal Biomaterial $72 3 payments
  8. ETHICON $68 2 payments
  9. Harmonic $57 1 payment
  10. ULTRA VAC $55 2 payments
  11. Other $413 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

71

Median for General Surgery: 59

Drug cost

$329

Median for General Surgery: $393

Branded share of claims

67.6%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 48 $290
Tramadol Hcl Generic 23 $39

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 71 billing codes

Paid by Medicare

$210,018

Medicare's payments for the services billed

Medicare patients

201

Average age 73

Services billed

552

99 women, 102 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 50%
Diabetes 42%
Ischemic heart disease 37%
COPD 29%
Cancer 26%
Heart failure 25%
Atrial fibrillation 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

86 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record